Market Publishers Ltd and Roots Analysis Sign Partnership Agreement
24 Oct 2016 • by Natalie Aster
LONDON – Market Publishers Ltd and Roots Analysis signed a partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorised to distribute and sell research reports prepared by Roots Analysis.
Natalie Aster, Assistant Manager at Partners Department, commented on the partnership agreement: “We are excited to announce that a new market intelligence and consulting firm, Roots Analysis, has recently joined our group of publishers. The company is focused on delivering informative and unbiased insights into key issues facing the pharmaceutical industry, covering such aspects as technology evolution, R&D, current market landscape, future commercial prospects, regulatory issues, growth drivers, opportunities and risks, among others. Besides creating reports on the pertinent areas, Roots Analysis also provides bespoke research and consulting services aimed at serving their clients at the best advantage. We are confident that our cooperation will lead to remarkable outcomes for both parties and, beyond a shadow of doubt, for our multinational customers worldwide.”
Comprehensive market research reports by Roots Analysis:
Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030. Currently, over 75% of the therapeutic vaccines within the immuno-oncology sector are in the clinical development stages. With an extensive development pipeline, this immunotherapy market segment has found a way to grab the interest of some strategic investors and VC firms. Over the last 5 years, this domain has seen an investment of more than USD 1.5 billion. Due to the present-day unmet demand for effective and safe cancer therapies and considering the innate benefits of immunotherapies, dendritic cell and tumor cell cancer vaccines will likely create lucrative opportunities for investors and therapy developers alike. More essential details on the marketplace can be found in the research study…
Smart Wearables in Healthcare, 2016-2030. An immense portion of innovation in the smart wearables field is focused on the healthcare domain. The market is extremely fragmented. Notwithstanding the presence of novel players, several renowned non-healthcare stakeholders like Apple, Asus, Huawei, LG, Adidas, Nike, Samsung, Sony, among others, have fortified their market position, specifically in activity and/or fitness tracking. The report offers a granular analysis of the today’s market landscape and limelights the prospects of smart wearables in the healthcare universe. It reviews a diversity of applications of smart wearables across a broad range of sectors; gives a holistic view of developments influencing today’s healthcare setup and that are set to drive considerable changes in the approaches to healthcare management in the offing…
HDAC Inhibitors Market, 2016 – 2026. The market has evolved at a steady pace over the past several years, with many drug candidates created to address a vast scope of non-oncological and oncological disorders. With 5 commercialized products, the market has grabbed attention from a few of players. To date, the HDAC (histone deacetylase) inhibitors’ pipeline consists of more than 90 molecules in the development stage. In the recent past, there has been a shift from pan-HDAC to class-specific HDAC inhibitors. Surging popularity of social media explains the soaring interest in the field. During 2009-2015, the CAGR in the tweets registered on Twitter reached 33%. Analogous trends have been witnessed on Facebook. The study presents a refined market forecast and opportunity assessment to 2026, comprising projected sales of the approved drug products and the ones in phase III and phase II trials. More valuable information is given in the publication…
More details on the publisher and its research reports can be found at Roots Analysis page.